G
Guanghui Ma
Researcher at Chinese Academy of Sciences
Publications - 519
Citations - 21012
Guanghui Ma is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Membrane emulsification & Antigen. The author has an hindex of 66, co-authored 497 publications receiving 17108 citations. Previous affiliations of Guanghui Ma include Center for Advanced Materials & Nanjing Tech University.
Papers
More filters
Journal ArticleDOI
Comparative Studies on the Influences of Primary Emulsion Preparation on Properties of Uniform-Sized Exenatide-Loaded PLGA Microspheres
TL;DR: Comparing the properties of microspheres whose W1/O was formed by ultrasonication (UMS) and homogenization (HMS) were compared including in vitro release, pharmacology and so forth can provide guidance for emulsion-microsphere preparation routs in pharmaceutics.
Journal ArticleDOI
A hydrophobic interaction chromatography strategy for purification of inactivated foot-and-mouth disease virus
Hao Li,Yanli Yang,Yan Zhang,Songping Zhang,Qizu Zhao,Zhu Yuanyuan,Xingqi Zou,Mengran Yu,Guanghui Ma,Zhiguo Su +9 more
TL;DR: A purification scheme based on hydrophobic interaction chromatography was developed to separate inactivated foot-and-mouth disease virus (FMDV) from crude supernatant, and the purified virus contained the required antigen, and was structurally intact with a spherical shape and a particle size of 28 nm.
Journal ArticleDOI
A rapid, non-invasive and non-destructive method for studying swelling behavior and microstructure variations of hydrogels
TL;DR: This method was successfully applied to swelling ratio determination of chitosan/glutaraldehyde (CS/GA) hydrogels in situ, and the results had better accuracy and repeatability compared with that of weighing method.
Journal ArticleDOI
A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
TL;DR: The results suggest that rhGH-PELA microspheres have the potential to be clinically effective and safe when administered only once every two months, a dose regimen for better patient acceptance and compliance.
Journal ArticleDOI
Engineering and delivery of nanocolloids of hydrophobic drugs.
TL;DR: This review focuses on the evaluation of pure drug nanolloids fabricated by different engineering protocols with emphasis on the size and morphology, delivery and controlled release, and therapeutic effects of these drug nanocolloids.